| Authors: |
Larønningen S; Department of Registration, Cancer Registry of Norway, Oslo, Norway., Skog A; Department of Registration, Cancer Registry of Norway, Oslo, Norway., Engholm G; Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark., Ferlay J; Cancer Surveillance Branch, International Agency for Research on Cancer, Lyon, France., Johannesen TB; Department of Registration, Cancer Registry of Norway, Oslo, Norway., Kristiansen MF; University of the Faroe Islands, Faculty of Health Sciences, Tórshavn, Faroe Islands., Knoors D; Research and Development, Netherlands Comprehensive Cancer Organisation, Eindhoven, Netherlands., Kønig SM; Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark., Olafsdottir EJ; The Icelandic Cancer Registry, Reykjavik, Iceland., Pejicic S; The National Board of Health and Welfare, Stockholm, Sweden., Pettersson D; The National Board of Health and Welfare, Stockholm, Sweden., Skovlund CW; Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark., Storm HH; Cancer Surveillance and Pharmacoepidemiology, Danish Cancer Society Research Center, Copenhagen, Denmark., Tian H; Department of Registration, Cancer Registry of Norway, Oslo, Norway., Aagnes B; Department of Registration, Cancer Registry of Norway, Oslo, Norway., Miettinen J; Finnish Cancer Registry, Helsinki, Finland. |